Parsing anhedonia: Effort-based decision-making as a translational model of motivational deficits in Major Depressive Disorder

[1]  K. Kendler,et al.  The dappled nature of causes of psychiatric illness: replacing the organic–functional/hardware–software dichotomy with empirically based pluralism , 2012, Molecular Psychiatry.

[2]  Benjamin A. Ely,et al.  Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. , 2012, Archives of general psychiatry.

[3]  Christian E. Waugh,et al.  Anticipatory pleasure predicts motivation for reward in major depression. , 2012, Journal of abnormal psychology.

[4]  H. de Wit,et al.  Amping Up Effort: Effects of d-Amphetamine on Human Effort-Based Decision-Making , 2011, The Journal of Neuroscience.

[5]  L. Fellows,et al.  Acute Phenylalanine/Tyrosine Depletion Reduces Motivation to Smoke Cigarettes Across Stages of Addiction , 2011, Neuropsychopharmacology.

[6]  G. Waiter,et al.  Expected value and prediction error abnormalities in depression and schizophrenia. , 2011, Brain : a journal of neurology.

[7]  Sohee Park,et al.  Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions. , 2011, The American journal of psychiatry.

[8]  Yuri Miyamoto,et al.  The Role of Utility Value in Achievement Behavior: The Importance of Culture , 2011, Personality & social psychology bulletin.

[9]  Mathias Pessiglione,et al.  Separate Valuation Subsystems for Delay and Effort Decision Costs , 2010, The Journal of Neuroscience.

[10]  S. Hyman,et al.  Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.

[11]  C. Winstanley,et al.  Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the five-choice serial reaction time task , 2010, Behavioural Brain Research.

[12]  Mark Slifstein,et al.  Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride , 2010, Synapse.

[13]  J. D. Watson,et al.  The Future of Psychiatric Research: Genomes and Neural Circuits , 2010, Science.

[14]  Robert M. Kessler,et al.  Mesolimbic Dopamine Reward System Hypersensitivity in Individuals with Psychopathic Traits , 2010, Nature Neuroscience.

[15]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[16]  W. Ishak,et al.  The role of dopaminergic agents in improving quality of life in major depressive disorder , 2009, Current psychiatry reports.

[17]  M. Ernst,et al.  The Effects of Psychotherapy on Neural Responses to Rewards in Major Depression , 2009, Biological Psychiatry.

[18]  A. Arnsten,et al.  Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology , 2009, CNS Drugs.

[19]  Kyle S. Smith,et al.  Dynamic Computation of Incentive Salience: “Wanting” What Was Never “Liked” , 2009, The Journal of Neuroscience.

[20]  E. Donny,et al.  Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats , 2009, Psychopharmacology.

[21]  G. Goodwin,et al.  Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. , 2009, The British journal of psychiatry : the journal of mental science.

[22]  T. Trull,et al.  Clinical assessment of affective instability: comparing EMA indices, questionnaire reports, and retrospective recall. , 2009, Psychological assessment.

[23]  T. Robbins,et al.  Serotonergic and Dopaminergic Modulation of Gambling Behavior as Assessed Using a Novel Rat Gambling Task , 2009, Neuropsychopharmacology.

[24]  P. Cowen,et al.  Neural representation of reward in recovered depressed patients , 2009, Psychopharmacology.

[25]  Jeffrey L. Birk,et al.  Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. , 2009, The American journal of psychiatry.

[26]  Peter Boesiger,et al.  The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. , 2009, Archives of general psychiatry.

[27]  Timothy Edward John Behrens,et al.  Effort-Based Cost–Benefit Valuation and the Human Brain , 2009, The Journal of Neuroscience.

[28]  L. Green,et al.  Dopamine modulates effort-based decision making in rats. , 2009, Behavioral neuroscience.

[29]  Christopher S. Monk,et al.  Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. , 2009, Archives of general psychiatry.

[30]  Antoine Bechara,et al.  The hidden island of addiction: the insula , 2009, Trends in Neurosciences.

[31]  N. Paterson.  Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights. , 2009, European journal of pharmacology.

[32]  Stan B. Floresco,et al.  Cortico-limbic-striatal circuits subserving different forms of cost-benefit decision making , 2008, Cognitive, affective & behavioral neuroscience.

[33]  Martin P Paulus,et al.  Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain. , 2008, Archives of general psychiatry.

[34]  A. Yung,et al.  A factor analytic investigation of the Tripartite model of affect in a clinical sample of young Australians , 2008, BMC psychiatry.

[35]  M. Lemke.  Dopamine agonists in the treatment of non‐motor symptoms of Parkinson’s disease: depression , 2008, European journal of neurology.

[36]  J. Waltz,et al.  Reward processing in schizophrenia: a deficit in the representation of value. , 2008, Schizophrenia bulletin.

[37]  Colin Camerer,et al.  Dissociating the Role of the Orbitofrontal Cortex and the Striatum in the Computation of Goal Values and Prediction Errors , 2008, The Journal of Neuroscience.

[38]  H. Anisman,et al.  Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders , 2008, Progress in Neurobiology.

[39]  P. Chen,et al.  Greater availability of dopamine transporters in patients with major depression — A dual-isotope SPECT study , 2008, Psychiatry Research: Neuroimaging.

[40]  Lauren M. Bylsma,et al.  A meta-analysis of emotional reactivity in major depressive disorder. , 2008, Clinical psychology review.

[41]  Brian Knutson,et al.  Individual Differences in Insular Sensitivity During Loss Anticipation Predict Avoidance Learning , 2008, Psychological science.

[42]  A. Grace,et al.  The Yin and Yang of dopamine release: a new perspective , 2007, Neuropharmacology.

[43]  John T. Mitchell,et al.  The interaction of reinforcement sensitivity and life events in the prediction of anhedonic depression and mixed anxiety-depression symptoms , 2007 .

[44]  S. Hollon,et al.  Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? , 2007, Journal of consulting and clinical psychology.

[45]  J. Amsterdam,et al.  A Preliminary Study of Dopamine Transporter Binding in Bipolar and Unipolar Depressed Patients and Healthy Controls , 2007, Neuropsychobiology.

[46]  Janneke Koerts,et al.  Striatal dopaminergic activity (FDOPA‐PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease , 2007, The European journal of neuroscience.

[47]  W. Schultz.  Behavioral dopamine signals , 2007, Trends in Neurosciences.

[48]  D. Surmeier,et al.  D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons , 2007, Trends in Neurosciences.

[49]  J. Krystal,et al.  The NMDA receptor as a therapeutic target in major depressive disorder. , 2007, CNS & neurological disorders drug targets.

[50]  K. Berridge.  The debate over dopamine’s role in reward: the case for incentive salience , 2007, Psychopharmacology.

[51]  Justin S. Feinstein,et al.  Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. , 2007, The American journal of psychiatry.

[52]  A. Schene,et al.  Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies , 2007, Molecular Psychiatry.

[53]  M. Thase,et al.  Increased Amygdala and Decreased Dorsolateral Prefrontal BOLD Responses in Unipolar Depression: Related and Independent Features , 2007, Biological Psychiatry.

[54]  G. Loewenstein,et al.  Neural Predictors of Purchases , 2007, Neuron.

[55]  J. Pettit,et al.  Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales. , 2006, Journal of clinical psychology.

[56]  Alan A. Wilson,et al.  Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. , 2006, The American journal of psychiatry.

[57]  R. Dolan,et al.  Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans , 2006, Nature.

[58]  M. Paulus,et al.  An Insular View of Anxiety , 2006, Biological Psychiatry.

[59]  David C. Atkins,et al.  Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. , 2006, Journal of consulting and clinical psychology.

[60]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[61]  Mohammad Sib Ansari,et al.  Amphetamine-Induced Displacement of [18F] Fallypride in Striatum and Extrastriatal Regions in Humans , 2006, Neuropsychopharmacology.

[62]  M. Thase,et al.  Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. , 2006, The American journal of psychiatry.

[63]  S. Shankman,et al.  Behavioral activation system deficits predict the six-month course of depression. , 2006, Journal of affective disorders.

[64]  M. Zimmerman,et al.  Diagnosing Major Depressive Disorder Introduction: An Examination of the DSM-IV Diagnostic Criteria , 2006, The Journal of nervous and mental disease.

[65]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[66]  D. S. Zahm,et al.  Specificity in the Projections of Prefrontal and Insular Cortex to Ventral Striatopallidum and the Extended Amygdala , 2005, The Journal of Neuroscience.

[67]  Steven C. R. Williams,et al.  The Neural Correlates of Anhedonia in Major Depressive Disorder , 2005, Biological Psychiatry.

[68]  Mary L. Phillips,et al.  A Double Dissociation of Ventromedial Prefrontal Cortical Responses to Sad and Happy Stimuli in Depressed and Healthy Individuals , 2005, Biological Psychiatry.

[69]  M. Fava,et al.  Ropinirole in Treatment-Resistant Depression: A 16-Week Pilot Study , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[70]  M. Walton,et al.  Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort , 2005, Psychopharmacology.

[71]  A. Harrison,et al.  Paroxetine combined with a 5-HT1A receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats , 2005, Psychopharmacology.

[72]  D. Pizzagalli,et al.  Toward an objective characterization of an anhedonic phenotype: A signal-detection approach , 2005, Biological Psychiatry.

[73]  Bradley T. Christian,et al.  Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET , 2005, Brain Research.

[74]  Michael Koch,et al.  Dopamine in the orbitofrontal cortex regulates operant responding under a progressive ratio of reinforcement in rats , 2004, Neuroscience Letters.

[75]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[76]  I. Lucki,et al.  Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Jogeshwar Mukherjee,et al.  Measuring the in Vivo Binding Parameters of [18F]-Fallypride in Monkeys Using a PET Multiple-Injection Protocol , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  R. Shelton,et al.  Assessing the effects of bupropion SR on mood dimensions of depression. , 2004, Journal of affective disorders.

[79]  L. Jasmin,et al.  Rostral agranular insular cortex and pain areas of the central nervous system: A tract‐tracing study in the rat , 2004, The Journal of comparative neurology.

[80]  Robert B. Innis,et al.  Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naı̈ve healthy volunteers: results from a large cohort , 2003, European Neuropsychopharmacology.

[81]  Benoit M. Dawant,et al.  The adaptive bases algorithm for intensity-based nonrigid image registration , 2003, IEEE Transactions on Medical Imaging.

[82]  M. Bergström,et al.  In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography , 2003, Biological Psychiatry.

[83]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[84]  Eric Vermetten,et al.  Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. , 2003, JAMA.

[85]  S. Haber,et al.  Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[86]  John Suckling,et al.  Neural response to pleasant stimuli in anhedonia: an fMRI study , 2003, Neuroreport.

[87]  I. Gotlib,et al.  Behavioral activation and inhibition systems and the severity and course of depression. , 2002, Journal of abnormal psychology.

[88]  Alan A. Wilson,et al.  Bupropion occupancy of the dopamine transporter is low during clinical treatment , 2002, Psychopharmacology.

[89]  Michael D. Robinson,et al.  Episodic and semantic knowledge in emotional self-report: evidence for two judgment processes. , 2002, Journal of personality and social psychology.

[90]  S. Hyman.  Neuroscience, Genetics, and the Future of Psychiatric Diagnosis , 2002, Psychopathology.

[91]  M. Thase,et al.  Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals , 2002, Biological Psychiatry.

[92]  S. J. Catanzaro,et al.  Cross-Cultural Examination of the Tripartite Model With Children: Data From the Barretstown Studies , 2001, Journal of personality assessment.

[93]  J. Salamone,et al.  Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement , 2001, Neuroscience.

[94]  Y. Hurd,et al.  D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain , 2001, Journal of Chemical Neuroanatomy.

[95]  N. Jacobson,et al.  Depression in Context: Strategies for Guided Action , 2001 .

[96]  R Jouvent,et al.  Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. , 2001, The American journal of psychiatry.

[97]  D. Kupfer,et al.  Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria , 2001, Biological Psychiatry.

[98]  J. Bargas,et al.  D2 Dopamine Receptors in Striatal Medium Spiny Neurons Reduce L-Type Ca2+ Currents and Excitability via a Novel PLCβ1–IP3–Calcineurin-Signaling Cascade , 2000, The Journal of Neuroscience.

[99]  Florian Holsboer,et al.  The Corticosteroid Receptor Hypothesis of Depression , 2000, Neuropsychopharmacology.

[100]  S. Stahl.  Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline , 2000, Biological Psychiatry.

[101]  R. Donahue,et al.  Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. , 2000, The Journal of clinical psychiatry.

[102]  H. Ågren,et al.  Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. , 2000, Archives of general psychiatry.

[103]  T. R. Wade,et al.  Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats , 2000, Psychopharmacology.

[104]  J. Azorin,et al.  Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder. , 2000, Psychiatric genetics.

[105]  D. Kupfer,et al.  Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[106]  J. Salamone,et al.  Nucleus Accumbens Dopamine Depletions and Time-Constrained Progressive Ratio Performance Effects of Different Ratio Requirements , 1999, Pharmacology Biochemistry and Behavior.

[107]  R. Depue,et al.  Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion , 1999, Behavioral and Brain Sciences.

[108]  J. Salamone,et al.  Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement , 1999, Neuroscience.

[109]  Wolfgang Gaebel,et al.  Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT , 1999, Psychiatry Research: Neuroimaging.

[110]  R. Donahue,et al.  A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. , 1999, Clinical therapeutics.

[111]  Y. Lecrubier,et al.  Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects , 1998, European Psychiatry.

[112]  R. Segraves,et al.  Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. , 1997, The Journal of clinical psychiatry.

[113]  K. Berridge,et al.  Pimozide Does Not Shift Palatability: Separation of Anhedonia from Sensorimotor Suppression by Taste Reactivity , 1997, Pharmacology Biochemistry and Behavior.

[114]  S. J. Gatley,et al.  Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.

[115]  R. Baldessarini,et al.  Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. , 1997, The Journal of clinical psychiatry.

[116]  J. Conner,et al.  Distribution of Brain-Derived Neurotrophic Factor (BDNF) Protein and mRNA in the Normal Adult Rat CNS: Evidence for Anterograde Axonal Transport , 1997, The Journal of Neuroscience.

[117]  Peter Dayan,et al.  A Neural Substrate of Prediction and Reward , 1997, Science.

[118]  M. Barrot,et al.  Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[119]  A. Beck,et al.  Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. , 1996, Journal of personality assessment.

[120]  F. Rougé-Pont,et al.  Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[121]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[122]  R. Palmiter,et al.  Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic , 1995, Cell.

[123]  R Ramana,et al.  Residual symptoms after partial remission: an important outcome in depression , 1995, Psychological Medicine.

[124]  J S Fowler,et al.  Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. , 1995, Archives of general psychiatry.

[125]  R A McCormick,et al.  Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. , 1995, Journal of abnormal psychology.

[126]  Christer Halldin,et al.  Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.

[127]  John D. Salamone,et al.  Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure , 1994, Pharmacology Biochemistry and Behavior.

[128]  R. Weisler,et al.  Comparison of bupropion and trazodone for the treatment of major depression. , 1994, Journal of clinical psychopharmacology.

[129]  L. Parker,et al.  Amphetamine-induced modification of quinine palatability: Analysis by the taste reactivity test , 1994, Pharmacology Biochemistry and Behavior.

[130]  J. Danion,et al.  Eating behaviour and depression before and after antidepressant treatment: a prospective, naturalistic study. , 1994, Journal of affective disorders.

[131]  J R Votaw,et al.  Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide , 1993, Synapse.

[132]  A. Grace,et al.  Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity , 1992, Synapse.

[133]  Athina Markou,et al.  Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration , 1992, Brain Research.

[134]  S. Kapur,et al.  Role of the dopaminergic system in depression , 1992, Biological Psychiatry.

[135]  B. Wells,et al.  Psychiatric applications of bromocriptine therapy. , 1990, The Journal of clinical psychiatry.

[136]  B. Hoebel,et al.  Microdialysis Studies of Brain Norepinephrine, Serotonin, and Dopamine Release During Ingestive Behavior Theoretical and Clinical Implications a , 1989, Annals of the New York Academy of Sciences.

[137]  B. Berger,et al.  Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine‐beta‐hydroxylase , 1989, The Journal of comparative neurology.

[138]  J. Amsterdam,et al.  Taste and smell perception in depression , 1987, Biological Psychiatry.

[139]  H. de Wit,et al.  Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. , 1986, Drug and alcohol dependence.

[140]  P. Willner.  Dopamine and depression: A review of recent evidence. I. Empirical studies , 1983, Brain Research Reviews.

[141]  P. Willner.  Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments , 1983, Brain Research Reviews.

[142]  J. Mendels,et al.  A comparative study of bupropion and amitriptyline in depressed outpatients. , 1983, The Journal of clinical psychiatry.

[143]  M. Lader,et al.  Dependence on benzodiazepines. , 1983, The Journal of clinical psychiatry.

[144]  N C Andreasen,et al.  Negative symptoms in schizophrenia , 1982 .

[145]  J. Gerlach,et al.  Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients. , 1981, Journal of affective disorders.

[146]  H. Kraemer,et al.  CSF monoamine metabolites in depression and schizophrenia. , 1980, The American journal of psychiatry.

[147]  J. Korf,et al.  Cerebral monoamines and depression. An investigation with the Probenecid technique. , 1973, Archives of general psychiatry.

[148]  S. Vale,et al.  Amantadine in depression. , 1971, Lancet.

[149]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[150]  A. Grace,et al.  Cortico-Basal Ganglia Reward Network: Microcircuitry , 2010, Neuropsychopharmacology.

[151]  Bruce S. McEwen,et al.  Neurobiological and Clinical Effects of the Antidepressant Tianeptine , 2008, CNS drugs.

[152]  David Taylor,et al.  Psychostimulants in the Treatment of Depression , 2007, CNS drugs.

[153]  W. Schultz.  Behavioral theories and the neurophysiology of reward. , 2006, Annual review of psychology.

[154]  C. Hammen.  Stress and depression. , 2005, Annual review of clinical psychology.

[155]  J. Salamone,et al.  Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure , 2005, Psychopharmacology.

[156]  K. Krishnan,et al.  Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. , 2003, Psychopharmacology bulletin.

[157]  Dwight L. Evans,et al.  Comparison of pramipexole, fluoxetine, and placebo in patients with major depression , 2000, Depression and anxiety.

[158]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[159]  H. Ågren,et al.  PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. , 1994, Pharmacopsychiatry.

[160]  H. Berenbaum,et al.  Emotional experience and expression in schizophrenia and depression. , 1992, Journal of abnormal psychology.

[161]  W. Iacono,et al.  Neurobehavioral aspects of affective disorders. , 1989, Annual review of psychology.

[162]  D. Hedeker,et al.  Differences between anhedonic and normally hedonic depressive states. , 1983, The American journal of psychiatry.

[163]  J. Feighner,et al.  Diagnostic criteria for use in psychiatric research. , 1972, Archives of general psychiatry.

[164]  C. W. Metz.  The Role of the , 1934 .